Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Aikido Pharma Has Licensed DHA-dFdC at The University of Texas at Austin

Released On: 05/03/2021
Views: 709

Aikido Pharma Shares Published Papers and Articles on KPC-34 and DHA-dFdC

Released On: 03/03/2021
Views: 684

Aikido Pharma Announces Findings of Positive Results From New Drug “DHA-dFdC” Developed at The University of Texas at Austin

Released On: 01/03/2021
Views: 728

AIkido Pharma Inc. to Present at the H.C. Wainwright Global Life Sciences Conference (Virtual Event)

Released On: 01/03/2021
Views: 1102

Meet Aikido Pharma Inc’s Board of Directors

Released On: 28/02/2021
Views: 729

AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering

Released On: 23/02/2021
Views: 770

Artificial Intelligence Is Optimizing Drug Development

Released On: 22/02/2021
Views: 777

Aikido Pharma Focuses on The Treatment of Four Main Types of Cancer

Released On: 20/02/2021
Views: 663

AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock

Released On: 19/02/2021
Views: 827

AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million

Released On: 16/02/2021
Views: 926

AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

Released On: 16/02/2021
Views: 878

AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment

Released On: 16/02/2021
Views: 965

Aikido Pharma Announces Information on KPC-34 Which Was Developed at the Wake Forest School of Medicine

Released On: 15/02/2021
Views: 677

Aikido Pharma Establishes Licensing Agreement with University of Maryland
for Antiviral Compounds, Including COVID-19

Released On: 10/02/2021
Views: 591

Aikido Pharma Announces DHA-dFdC Which Is Licensed From the University of Texas at Austin for the treatment of Pancreatic Cancer.

Released On: 09/02/2021
Views: 1135

Aikido Pharma Secures Early Interest in Convergent Therapeutics, Inc. Who Focuses On Next Generation Radiopharmaceutical Therapy for Prostate Cancer

Released On: 05/02/2021
Views: 731

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

Released On: 03/02/2021
Views: 1587

Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics

Released On: 03/02/2021
Views: 802


Aikido Pharma

Get Directions

Aikido Pharma

  • One Rockefeller Plaza
    New York, New York 10020
    United States
  • (212) 745-1373